Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
BERGONIÉ INSTITUTE maintains a presence in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This active matter is assigned to 1 distinct examiner and 1 distinct art unit, indicating that the institute's current patent prosecution is concentrated in a single administrative area. Such a profile suggests a very narrow engagement with the patent office regarding the institute's current technical filings. Practitioners should observe that the 1 distinct art unit involved provides a consistent environment for the current prosecution effort.
The busiest examiner for this portfolio is PAULUS, ERIN VIRGINIA, who is responsible for 1 busiest examiner pending office action. This count matches the total of 1 pending office action for the entire portfolio, showing that this examiner handles all current legal proceedings. Because there is only 1 distinct examiner, the prosecution environment is highly centralized for the applicant. Practitioners should note that the 1 busiest examiner pending office action represents the total active workload, requiring focused attention on this single individual's review process to ensure the institute's patent goals are met.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAULUS, ERIN VIRGINIA | 1 | 20.0% | +94.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17925291 | IN VITRO METHOD FOR THE PROGNOSIS OF DISEASE PROGRESSION IN A PATIENT THAT SUFFERS FROM OR IS AT RISK OF DEVELOPING A SOLID TUMOR | PAULUS, ERIN VIRGINIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17925291 | IN VITRO METHOD FOR THE PROGNOSIS OF DISEASE PROGRESSION IN A PATIENT THAT SUFFERS FROM OR IS AT RISK OF DEVELOPING A SOLID TUMOR | PAULUS, ERIN VIRGINIA | — |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17925291 | IN VITRO METHOD FOR THE PROGNOSIS OF DISEASE PROGRESSION IN A PATIENT THAT SUFFERS FROM OR IS AT RISK OF DEVELOPING A SOLID TUMOR | PAULUS, ERIN VIRGINIA | 1631 | §101§102§103§112 | Non-Final OA | — | Pending | Nov 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBERGONIÉ INSTITUTE has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Erin Virginia Paulus has the most, with 1 of BERGONIÉ INSTITUTE's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
